Invesaro

Stocks Health care NYXH

NASDAQ · Health care

Nyxoah SA (NYXH)

It posted a net loss of €90.1M. In fiscal 2025 capital spending exceeded operating cash flow by €69.8M. At December 31, 2025 it held €30M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 26, 2026.

Free, no password. An email when NYXH files with the SEC.

Price
$0.87
-2.56% on the day · November 10, 2026
52-week range $0.80 to $5.92
Market cap
$38M

Key facts about Nyxoah SA

Net worth
Nyxoah SA has a market value (market cap) of $38M at the latest share price, and shareholders' equity of €49.1M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Cash flow
In fiscal 2025 operations used €69M of cash.
Latest report
The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on March 26, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR

What Nyxoah SA does

Nyxoah SA is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker NYXH.

Revenue and profit by year

Net income
FY20: -€12.2M -€12.2M FY20FY22: -€27.6M -€27.6M FY22FY22: -€31.2M -€31.2M FY22FY23: -€43.2M -€43.2M FY23FY24: -€59.2M -€59.2M FY24FY25: -€90.1M -€90.1M FY25

Fiscal years as reported in annual reports. Amounts in EUR.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025n/a-€83.5M-€90.1M-€2.36-€69.8M
2024n/a-€58.8M-€59.2M-€1.81-€50.4M
2023n/a-€45.1M-€43.2M-€1.55-€47.3M
2022n/a-€32.5M-€31.2M-€1.21-€29.6M
2022n/a-€26.2M-€27.6M-€1.16-€26.8M
2020n/a-€11.2M-€12.2M-€0.68-€7.4M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Nyxoah SA has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 29, 2026
  2. September 22, 2026
  3. August 14, 2026
  4. August 5, 2026
  5. July 9, 2026
  6. July 1, 2026
  7. June 23, 2026
  8. June 22, 2026
  9. June 11, 2026
  10. June 11, 2026

Insider trades

What the people running Nyxoah SA did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns NYXH

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Orin Hirschman13G, passive with 1 related filers 14.5% 14,534,880 June 22, 2026
CVI Investments, Inc.13G, passive with 1 related filers 9.9% 11,014,861 August 14, 2026
Cochlear Investments Pty Ltd13D, may seek influence with 1 related filers 5.91% 5,847,283 June 11, 2026

Latest filings below 5%: Vestal Point Capital, LP 3.7% (August 14, 2025).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 45 managers reported a position.

HolderSharesValueChange on quarter
AIGH Capital Management LLC14,534,880$24.6Mnew
BNP PARIBAS ASSET MANAGEMENT Holding S.A.962,524$1.7M+208,185
Axxion S.A.904,895$1.6Mnew
Blackstone Inc.921,500$1.6Mnew
Vestal Point Capital, LP843,461$1.4M-25,200
Heights Capital Management, Inc828,803$1.4M+520,313
Hudson Bay Capital Management LP717,982$1.2Mnew
Pentwater Capital Management LP600,000$1Mnew
Andera Partners522,057$882.3K0
Readystate Asset Management LP207,471$350.6Knew
Rossmore Private Capital132,746$229.5K0
BlackRock, Inc.121,207$204.8K-387,584
IFP Advisors, Inc118,426$200.1K+31,061
Integrated Wealth Concepts LLC100,000$169Knew
Citadel Advisors LLC80,195$135.5Knew
Ikarian Capital, LLC47,358$80K0
Geode Capital Management, LLC44,802$75.7K+23,617
Jane Street Group, LLC43,544$75.2Knew
LPL Financial LLC36,261$61.3K0
UBS Group AG35,649$60.2Knew

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

No insider reported holdings on a Form 4 in the last 12 months.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about NYXH

What does Nyxoah SA do?

Nyxoah SA is a company in the Health care sector, listed on NASDAQ as NYXH. Its shares trade on NASDAQ under the ticker NYXH.

What is Nyxoah SA's net worth?

Nyxoah SA has a market value (market cap) of $38M at the latest share price, and shareholders' equity of €49.1M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Nyxoah SA profitable?

No. In fiscal 2025 it reported a net loss of €90.1M.

When did Nyxoah SA last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 26, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 29, 2026.

Similar companies

Compare NYXH with

Compare NYXH with any company

Follow NYXH

Get an email when Nyxoah SA files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when NYXH files with the SEC.

Where the numbers come from

Financial figures are the values Nyxoah SA tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.